Stay updated with breaking news from Emylee Thai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Artemis DNA, a clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic testing that enables precision medicine through early disease detection in the US, has reserved 100 VinFast EVs. Immediately after VinFast’s debut at CES 2022 of its electric vehicles (earlier post), Artemis DNA decided to...
/PRNewswire/ -- Artemis DNA, Inc. ("Artemis DNA" or the "company"), a full-service, accredited, high complexity clinical diagnostic laboratory company...
/PRNewswire/ -- Artemis DNA, Inc. ("Artemis DNA" or the "company"), a full-service, accredited, high complexity clinical diagnostic laboratory company...
Artemis DNA has become the first US firm to place an order to purchase 100 electric cars of VinFast following the Vietnamese automaker’s new model debut at the technology exhibition CES 2022 in Las Vegas, the United States.
Press release content from News Direct Corporation. The AP news staff was not involved in its creation.